Circassia Pharmaceuticals (LON:CIR)

Circassia Pharmaceuticals (LON:CIR)

Share Price
20.40 p
1.75 (9.38 %)
Market Cap
£76.53 m
Proactive Investors - Run By Investors For Investors

Circassia Pharmaceuticals RNS Release

Block Listing Application

RNS Number : 3997D
Circassia Pharmaceuticals Plc
25 June 2019

25 June 2019

Circassia Pharmaceuticals plc

Block Listing Application

Circassia Pharmaceuticals plc ("Circassia" or "the Company") today announces that an application (the "Application") has been made to the London Stock Exchange for a block listing of 930,000 ordinary shares of 0.08 pence each in the Company ("Ordinary Shares") to be admitted to trading on AIM.

The Application relates to Ordinary Shares to be issued from time to time in order to satisfy the potential exercise of share options granted under the 2016 Performance Share Plan Scheme.

It is expected that admission will become effective on 1 July 2019. When issued, the Ordinary Shares will rank pari passu with the existing ordinary shares of the Company.


For further information, please contact:

Circassia Pharmaceuticals plc

Julien Cotta, Company Secretary                                                     Tel: +44 (0) 1865 405 560

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit

Circassia Pharmaceuticals Timeline

© Proactive Investors 2019

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use